ORLANDO, Florida — Among patients with ischemic myocardial injury after noncardiac surgery (MINS), those who then received daily dabigatran (Pradaxa, Boehringer Ingelheim) showed a significant 28% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback